LewisS., HolmesC.Host defense mechanisms in the peritoneal cavity of continuous ambulatory peritoneal dialysis patients.Perit Dial Int.1991; 11: 14–21.
2.
GoldsteinC.S., BomalskiJ.S., ZurierR.B., NeilsonE.G., DouglasS.D.Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis.Kidney Int.1984; 26: 733–40.
3.
BrulezH.F., VerbrughH.A.First-Iine defense mechanisms in the peritoneal cavity during peritoneal dialysis.Perit Dial Int.1995; 15(7, Suppl): S24–33.
4.
AlobaidiH.M., ColesG.A., DaviesM., LloydD.Host defence in continuous ambulatory peritoneal dialysis: The effect of the dialysate on phagocyte function.Nephrol Dial Transplant.1986; 1: 16–21.
5.
DuweA.K., VasS.I., WeatherheadJ.W.Effects of the composition of peritoneal dialysis fluid on chemilumines cence, phagocytosis and bactericidal activity in vitro.Infect Immun.1981; 33: 130–5.
6.
Van BronswijkH., VerbrughH.A., HeeziusHJCM, Van der MeulenJ., OeP.L., VerhoefJ.Dialysis fluid and local host resistance in continuous ambulatory peritoneal dialysis.Eur J Clin Microbiol Infect Dis.1988; 7: 368–73.
7.
GallimoreB., GagnonR., RichardsG.Response of chronic renal failure mice to peritoneal Staphylococcus epidermidis challenge: Impact of repeated peritoneal instillation of dialysis solution.Am J Kidney Dis.1989; 14: 184–95.
8.
JörresA., JörresD., GahlG.M., KesslerM., MullerC., KottgenE.Leukotriene B4 and tumor necrosis factor release from leukocytes: Effect of peritoneal di alysate.Nephron.1991; 58: 276–82.
KeaneW.F., ComtyC.M., VerbrughH.A., PetersonP.K.Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis.Kidney Int.1984; 25: 539–43.
11.
DaviesS.J.Peritoneal lymphocyte populations in CAPD patients.Contrib Nephrol.1990; 85: 16–23.
12.
CichockiT., HanickiZ., SulowiczW., SmolenskiO., KopecJ., ZembalaM.Output of peritoneal cells into peritoneal dialysate. Cytochemical and functional studies.Nephron.1983; 35: 175–82.
13.
BosH.J., Van BronswijkH., HelmerhorstT.J., OeP.L., HoefsmitE.C., BeelenR.H.Distinct subpopulations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparoscopy: A study on peroxidatic activity.J Leukoc Biol.1988; 43: 172–8.
14.
MacGowanA.P., PetersonP.K., KeaneW., QuieP.G.Human peritoneal macrophage phagocytic, killing, and chemiluminescent responses to opsonized Listeria monocytogenes.Infect Immun.1983; 40: 440–3.
15.
BetjesM.G., TukC.W., StruijkD.G., KredietR.T., AriszL., BeelenR.H.Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis.Clin Exp Immunol.1993; 94: 377–84.
16.
LewisS.L., NorrisP.J., HolmesC.J.Phenotypic characterization of monocytes and macrophages from CAPD patients.ASAIO Trans.1990; 36: M575–7.
17.
VerbrughH.A., KeaneW.F., ConroyW.E., PetersonP.K.Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.J Clin Microbial.1984; 20: 199–203.
18.
Bennett-JonesD.N., YewdallV.M., GillespieC.M., OggC.S., CameronJ.S.Strain differences in the opsonisation of Staphylococcus epidermidis.Perit Dial Int.1989; 9: 333–9.
19.
DunnD.L., BarkeR.A., AhrenholzD.H., HumphreyE.W., SimmonsR.L.The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications.Ann Surg.1984; 199: 37–43.
20.
GoldsteinC.S., BomalaskiJ.S., ZurierR.B., NeilsonE.G., DouglasS.D.Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.Kidney Int.1984; 26: 733–40.
21.
PetersonP.K., GazianoE., SuhH.J., DevalonM., PetersonL., KeaneW.F.Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages.Infect Immun.1985; 49: 212–18.
22.
BosH.J., StruijkD.G., TukC.W., de WeldJ.C., HelmerhostThJ, HoefsmitE.C.M.Characterization of peritoneal cells from continuous ambulatory peritoneal dialysis (CAPD) patients: An immunological and functional study [Abstract].J Leukoc Biol.1989; 46: 313.
23.
CarcamoC., Fernandez-CastroM., SelgasR., JimenezC., MolinaS., VaraF.Long-term continuous ambulatory peritoneal dialysis reduces the expression of CDllb, CD14, CD16, and CD64 on peritoneal macrophages.Perit Dial Int.1996; 16: 582–9.
24.
TopleyN., AlobaidiH.M., DaviesM., ColesG.A., WilliamsJ.D., LloydD.The effect of dialysate on peritoneal phagocyte oxidative metabolism.Kidney Int.1988; 34: 404–11.
25.
GallimoreB., GagnonR.F., StevensonM.M.Cytotoxicity of commercial peritoneal dialysis solutions towards peritoneal cells of chronically uremic mice.Nephron.1986; 43: 283–9.
26.
LewisS.L., NorrisP.J.Monocyte/macrophage function in CAPD patients.Contrib Nephrol.1990; 85: 1–9.
27.
de FijterC.W., VerbrughH.A., PetersE.D., OeP.L., van der MeulenJ., VerhoefJ.In uiuo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.Clin Nephrol.1993; 39: 75–80.
McGregorS.J., BrockJ.H., BriggsJ.D., JunorB.J.Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls.Clin Immunol Immunopathol.1990; 56: 151–8.
30.
DaviesS.J., SuassunaJ., OggC.S., CameronJ.S.Activation of immunocompetent cells in the peritoneum of patients treated with CAPD.Kidney Int.1989; 36: 661–8.
31.
de FijterC.W.H., VerbrughH.A., PetersE.D.J., OeP.L., van der MeulenJ., DonkerA.J.Another reason to restrict the use of a hypertonic glucose-based peritoneal dialysis fluid: Its impact on peritoneal macrophage function in uiuo. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1991; 7: 150–3.
32.
LiberekT., TopleyN., JörresA., PetersenM.M., ColesG.A., GahlG.M.Peritoneal dialysis fluid inhibition of polymorphonuclear leukocyte respiratory burst activation is related to the lowering of intracellular pH.Nephron.1993; 65: 260–5.
33.
DouvdevaniA., RapoportJ., KonfortyA., YulzariR., MoranA., ChaimovitzC.Intracellular acidification mediates the inhibitory effect of peritoneal dialysate on peritoneal macrophages.J Am Sac Nephrol.1995; 6: 207–13.
34.
LiberekT., TopleyN., JörresA., ColesG.A., GahlG.M., WilliamsJ.D.Peritoneal dialysis fluid inhibition of phagocyte function: Effects of osmolality and glucose concentration.J Am Sac Nephrol.1993; 3: 1508–15.
35.
MahioutA., MatataB.M., BrunkhorstR.Effect of glucose and pyruvate in acidic and non-acidic peritoneal dialysis fluids on leukocytes cell functions.Kidney Int.1997; 51: 860–7.
36.
CalameW., HendrickxR.J., NamavarF., OeL.P., BeelenR.H.Effect of glucose in dialysis fluid on antibacterial defence in the peritoneal cavity.J Infect.1995; 30: 227–33.
37.
JörresA., GahlG.M., FreiuIn uitro studies on the effect of dialysis solutions on peritoneal leukocytes.Perit Dial Int.1995; 15(7, Suppl): S41–6.
38.
KoobsD.H.Phosphate mediation of the Crabtree and Pasteur effects.Science.1972; 178: 127–33.
39.
JörresA., JörresD., TopleyN., GahlG.M., MahioutA.Leukotriene release from peripheral and peritoneal leukocytes following exposure to peritoneal dialysis solutions.Nephrol Dial Transplant.1991; 6: 495–501.
40.
SteinhauerH.B., BruggerU., AtmanspacherR., Lubrich BirknerI., SchollmeyerP.Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G., eds. Advances in Peritoneal Dialysis.Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 47–52.
41.
DouvdevaniA., RapoportJ., KonfortyA., ZlotnikM., ChaimovitzC.The effect of peritoneal dialysis fluid on the release of IL-l beta and TNF alpha by macrophages/monocytes.Perit Dial Int.1993; 13: 112–17.
BrulezH.F., DekkerH.A., OeP.L., VerbeelenD., ter WeeP.M., VerbrughH.A.Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.Nephron.1996; 74: 26–32.
47.
SchenkU., KieferT., HübelE., WeberJ., Met tangT., Passlick-DeetjenJ.In vitro effects of amino-acid based versus glucose-based continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function.Nephron.1994; 68: 338–46.
48.
KieferT., SchenkU., HübelE., WeberJ., Met tangT., Passlick-DeetjenJ.In vitro effects of low-calcium peritoneal dialysis solution on peritoneal macrophage functions.Am J Kidney Dis.1995; 25: 751–60.
49.
de FijterC.W., VerbrughH.A., OeL.P.Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.Kidney Int.1992; 42: 947–50.
